Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
Bray F, Parkin DM, on behalf of the African Cancer Registry Network. Cancer in sub-saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol. 2022. https://doi.org/10.1016/S1470-2045(22)00270-4.
Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2020;20:30459–9.
IOC/IARC: Gambia Human papillomavirus and related cancers, Fact sheet. 2023; https://hpvcentre.net/statistics/reports/GMB_FS.pdf
World Health Organization: Cervical Cancer, fact sheet. 2024; https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
IARC (International Agency for Research on Cancer). A review of human carcinogens. Part B: Biological agents/IARC Working Group on the Evaluation of Carcinogenic Risks to humans. Human papillomaviruses, IARC monographs on the evaluation of carcinogenic risks to humans. 2011;100B:255–313.
de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country, and HPV type. Int J Cancer. 2017;141:664–70.
Article PubMed PubMed Central Google Scholar
Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta‐analysis update. Int J Cancer. 2007;121:621–32.
Article CAS PubMed Google Scholar
Clifford GM, Tully S, Franceschi S. Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clin Infect Dis. 2017;64:1228–35.
Article PubMed PubMed Central Google Scholar
Akakpo PK, Imbeah EG, Ulzen-Appiah K, Darkwa-Abrahams A. The distribution of hr HPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study. BMC Infect Dis. 2024;24(1):356. https://doi.org/10.1186/s12879-024-09166-7.
Article CAS PubMed PubMed Central Google Scholar
Abba K, Mwajim B, Haruna AN, Harun BR. Prevalence of human papillomavirus genotypes in cervical cancer in Maiduguri, Nigeria. Pan Afr Med J. 2019;33:284. https://doi.org/10.11604/pamj.2019.33.284.18338.
Niane K, Diagne Diop CT, Dia G, et al. Human papilloma virus genotypes associated with cervical cancer in Senegal. Biomed Res Rev. 2021;5:1–6.
Kuguyo O, Dube Mandishora RS, Thomford NE, Makunike-Mutasa R. High-risk HPV genotypes in Zimbabwean women with cervical cancer: comparative analyses between HIV-negative and HIV-positive women. PLoS ONE. 2021;16.
Bah Camara H, Anyanwu M, Wright, Kimmitt PT. Human papillomavirus genotype distribution and risk factor analysis in reproductive age women in urban Gambia. J Med Microbiol. 2018;67:1645–54.
Wall SR, Scherf CF, Morison L, et al. Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer. 2005;93:1068–76.
Article CAS PubMed PubMed Central Google Scholar
Mbaye EHS, Gheit T, Dem A, Mckay-Chopin S. Human papillomavirus infection in women in four regions of Senegal. J Med Virol. 2014;86:248–56.
Donkoh ET, Asmah RH, Agyemang-Yeboah F, Dabo EO. Prevalence and distribution of vaccine-preventable Genital Human Papillomavirus (HPV) genotypes in Ghanaian women presenting for screening. Cancer Control. 2022;29. https://doi.org/10.1177/10732748221094721.
Okolo C, Franceschi S, Adewole I, Thomas JO. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer. 2010;5:1–4. https://doi.org/10.1186/1750-9378-5-24.
Ayichew S, Nega A, Tadesse G, Berhanu S. Prevalence and genotype distribution of high-risk human papillomavirus infection among sub-saharan African women: a systematic review and Meta-analysis. Front Public Health. 2022;10:1–12. https://doi.org/10.3389/fpubh.2022.890880.
Guan P, Howell-Jones R, Bruni L, de Sanjose S. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349–59. https://doi.org/10.1002/ijc.27485.
Article CAS PubMed Google Scholar
Li N, Franceschi S, Howell-Jones R, Snijders PJ. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128:927–35. https://doi.org/10.1002/ijc.25396.
Article CAS PubMed Google Scholar
Witkiewicz AK, Wright TC, Ferenczy A, Ronnett BM, Kurman RJ. Carcinoma and other tumours of the Cervix, Blaustein’s Pathology of the Female Genital Tract. Springer. 2011;254–95.
Anna-Barbara M. Natural history of HPV infection in adolescents and relationship to Cervical Cancer, Molecular Pathology of Gynaecologic Cancer. Totowa, New Jersey: Humana. Springer.; 2007. pp. 103–12.
Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110(3 Suppl 2):S4–7.
Okolo C, Franceschi S, Adewole I, Thomas JO, et al. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer. 2010;5:24.
Article PubMed PubMed Central Google Scholar
Howitt BE, Herfs M, Tomoka T, Kamiza S, et al. Comprehensive Human Papillomavirus genotyping in cervical squamous cell carcinomas and its relevance to Cervical Cancer Prevention in Malawian Women. J Glob Oncol. 2017;3:227–34.
Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-saharan Africa. Int J Cancer. 2014;134:1389–98.
Article CAS PubMed Google Scholar
Dybikowska A, Licznerski P, Podhajska A. HPV detection in cervical cancer patients in northern Poland. Oncol Rep. 2002;9(4):871–4.
Mahmoodi P, Motamedi H, Abad Shapouri MRS, Shehni MB, Kargar M. Molecular detection and typing of human papillomaviruses in paraffin-embedded cervical Cancer and precancer tissue specimens. Iran J Cancer Prev. 2016;9:e3752.
PubMed PubMed Central Google Scholar
Biedermann K, Dandachi N, Trattner M, Vogl G, Doppelmayr H, Moré E, et al. Comparison of real-time PCR Signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in Archival Cervical Cancer tissue. J Clin Microbiol. 2004;42:3758–65.
Article CAS PubMed PubMed Central Google Scholar
Garland SM, Tabrizi S. Methods for HPV Detection: polymerase chain reaction assays, emerging issues on HPV infections, from Science to Practice. Basel Karger. 2006; 63–72.
de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al. Retrospective International Survey and HPV Time trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:104.
Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type, and year of publication. Int J Cancer. 2011;128:927–35.
Article CAS PubMed Google Scholar
Lagheden C, Eklund C, Lamin H, Kleppe SN, Lei J, et al. Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer. Br J Cancer. 2008;118:1377–81.
Liao L, Cheng H, Zeng F, Zhou W, Ding Y. Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China. J Clin Lab Anal. 2019;33:e22708.
International Agency for Research on Cancer (IARC). Handbooks of cancer prevention Vol 10: cervix cancer screening. 2005.
Muñoz N, Castellsagué X, Berrington de González A, Gissmann L. Chap. 1: HPV in the etiology of human cancer. Vaccine. 2006;24:1–10.
Salazar KL, Zhou HS, Xu J, Peterson LE, Schwartz MR, Mody DR, et al. Multiple human papillomavirus infections and their impact on the development of high-risk cervical lesions. Acta Cytol. 2015;59:391–8.
Missaoui N, Hmissa S, Trabelsi A, Tahar Yacoubi M, Nouira A, et al. Prevalence of HPV infection in precancerous and cancerous lesions of the uterine cervix in Tunisia. Ann Biol Clin (Paris). 2010;68:297–303.
Awua AK, Sackey ST, Osei YD, Asmah RH, Wiredu EK. Prevalence of human papillomavirus genotypes among women with cervical cancer in Ghana. Infect Agents Cancer. 2016;11:4.
Zohoncon TM, Quedraogo TC, Brun LVS, Obiri-Yeboah D, Djigma WF, Kabibou S, et al. Molecular Epidemiology of High-Risk Human Papillomavirus in High-Grade Cervical Intraepithelial Neoplasia and in Cervical Cancer in Parakou, Republic of Benin. Pak J Biol Sci. 2016;19:49–56.
留言 (0)